Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

1.

BCG immunotherapy of bladder cancer: 20 years on.

Alexandroff AB, Jackson AM, O'Donnell MA, James K.

Lancet. 1999 May 15;353(9165):1689-94. Review. No abstract available.

PMID:
10335805
[PubMed - indexed for MEDLINE]
2.

[Immunocompetence and immunotherapy of patients with cancer of the kidney and bladder].

Mokhort VA, Grigorovich NA, Strotskiĭ AV, Mavrichev AS.

Urol Nefrol (Mosk). 1986 Jan-Feb;(1):66-74. Review. Russian. No abstract available.

PMID:
3513423
[PubMed - indexed for MEDLINE]
3.

[Immunodiagnosis and immunotherapy of bladder tumors].

Kadagidze ZG, Shipilov VI.

Urol Nefrol (Mosk). 1984 Jan-Feb;(1):69-72. Review. Russian. No abstract available.

PMID:
6367184
[PubMed - indexed for MEDLINE]
4.

Immunotherapy in genitourinary neoplasia.

Droller MJ.

J Urol. 1985 Jan;133(1):1-5. Review. No abstract available.

PMID:
2578065
[PubMed - indexed for MEDLINE]
5.

Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.

Simons MP, Nauseef WM, Griffith TS.

Immunol Res. 2007;39(1-3):79-93. Review.

PMID:
17917057
[PubMed - indexed for MEDLINE]
6.

[The immunotherapy and immunoprophylaxis of bladder cancer].

Figurin KM, Tsiganu VI.

Urol Nefrol (Mosk). 1993 Jul-Aug;(4):46-9. Review. Russian. No abstract available.

PMID:
8310570
[PubMed - indexed for MEDLINE]
7.

T1G3 bladder cancer--the case for TUR and BCG.

Miller K.

Front Radiat Ther Oncol. 2002;36:147-50. Review. No abstract available.

PMID:
11842744
[PubMed - indexed for MEDLINE]
8.

[Immunotherapy in superficial bladder carcinoma].

Ríos González E, Martínez-Piñeiro Lorenzo L, Martínez-Piñeiro Caramés JA, de la Peña Barthel JJ.

Arch Esp Urol. 2000 Dec;53(10):879-92. Review. Spanish.

PMID:
11213392
[PubMed - indexed for MEDLINE]
9.

Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guérin (BCG) immunotherapy exist?. analysis of a quarter century of literature.

Saint F, Salomon L, Quintela R, Cicco A, Hoznek A, Abbou CC, Chopin DK.

Eur Urol. 2003 Apr;43(4):351-60; discussion 360-1. Review.

PMID:
12667715
[PubMed - indexed for MEDLINE]
10.

Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement.

Brandau S, Suttmann H.

Biomed Pharmacother. 2007 Jul;61(6):299-305. Epub 2007 Jun 12. Review.

PMID:
17604943
[PubMed - indexed for MEDLINE]
11.

BCG as adjuvant immunotherapy for neoplasia.

Hersh EM, Gutterman JU, Mavligit GM.

Annu Rev Med. 1977;28:489-515. Review. No abstract available.

PMID:
324372
[PubMed - indexed for MEDLINE]
12.

Management of complications of bacillus Calmette-Guérin immunotherapy in the treatment of bladder cancer.

Huang TC.

Ann Pharmacother. 2000 Apr;34(4):529-32. Review.

PMID:
10772442
[PubMed - indexed for MEDLINE]
13.

Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer.

Lamm DL.

Clin Infect Dis. 2000 Sep;31 Suppl 3:S86-90. Review.

PMID:
11010830
[PubMed - indexed for MEDLINE]
Free Article
14.

BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer.

Bassi P.

Surg Oncol. 2002 Jun;11(1-2):77-83. Review.

PMID:
12031870
[PubMed - indexed for MEDLINE]
15.

Aspects of non-specific immunotherapy with BCG in superficial bladder cancer: an overview.

van der Meijden AP, Debruyne FM, Steerenberg PA, de Jong WH.

Prog Clin Biol Res. 1989;310:11-33. Review. No abstract available.

PMID:
2672011
[PubMed - indexed for MEDLINE]
16.

Prostate cancer vaccines: current status.

Hwang LC, Fein S, Levitsky H, Nelson WG.

Semin Oncol. 1999 Apr;26(2):192-201. Review.

PMID:
10597730
[PubMed - indexed for MEDLINE]
17.

[Indications for BCG in surface tumors of the bladder].

Nogueira March JL, Ojea Calvo A, Rodríguez Iglesias B, Domínguez Freire F, Rodríguez Alonso A, Pérez García D, Alonso Rodríguez A, Barros Rodríguez JM, Benavente Delgado J.

Actas Urol Esp. 1999 Sep;23(8):643-56. Review. Spanish.

PMID:
10584342
[PubMed - indexed for MEDLINE]
18.

BCG immunotherapy for superficial bladder cancer.

Lockyer CR, Gillatt DA.

J R Soc Med. 2001 Mar;94(3):119-23. Review. No abstract available.

PMID:
11285791
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Evolving immunotherapeutic strategies in bladder and renal cancer.

Griffiths TR, Mellon JK.

Postgrad Med J. 2004 Jun;80(944):320-7. Review.

PMID:
15192163
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The management of superficial bladder cancer.

Oosterlinck W.

BJU Int. 2001 Jan;87(2):135-40. Review. No abstract available.

PMID:
11167630
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk